We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Adds Boxed Liver Warning to Hyperthyroidism Drug
FDA Adds Boxed Liver Warning to Hyperthyroidism Drug
April 23, 2010
The FDA has added a boxed warning to generic hyperthyroidism treatment propylthiouracil to include information about reports of severe liver injury and acute liver failure in patients taking the drug.